Drug Trial Radar · NCT06593392
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
18
Planned (sponsor's estimate)
Start
Aug 4, 2026
Primary completion
Aug 15, 2029
Study completion Aug 15, 2029
Sponsor
- Lead sponsor
- Vifor Fresenius Medical Care Renal PharmaIndustry
- Sponsor type
- Industry
- First posted
- Sep 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Rationale: * People with long term kidney disease who are on haemodialysis (a procedure for removing waste products from the blood) commonly develop a condition that makes their skin very itchy. * Difelikefalin is a medicine that can treat the itching related to long term kidney disease. * Clinical studies have shown difelikefalin to reduce itching in adults on haemodialysis, while being safe and tolerable. * The current study is being done in adolescents aged 12 to 17 years on haemodialysis who have moderate to severe itching related to long term kidney disease to assess if difelikefalin is safe in this age group. The aims of the study are: Main aim: To assess the safety of difelikefalin in adolescents who are on haemodialysis and have itching related to long term kidney disease Secondary aim: To measure the amount of difelikefalin that enters the blood in adolescents who are on haemodialysis and have itching related to long term kidney disease Study Design At least 18 adolescents, aged 12 to 17 years, who are on haemodialysis and have itching related to long term kidney disease will take part in this study. All study participants will receive difelikefalin 3 (or up to 4) times weekly for up to 12 weeks. The study duration for a participant is up to 17 to 18 weeks; during this period, participants will visit the clinic 3 times weekly (during their haemodialysis visits).
Conditions
- Pruritus
- Chronic Kidney Diseases
Interventions
DifelikefalinDrug
The study includes a screening period of up to 4 weeks (including a 7-day run-in period during the week prior to enrolment), a study treatment period of 12 weeks, and a safety follow-up visit at 7 (up to 10) days after EoT. Total study duration for a single participant is up to 17 to 18 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of adverse events (AEs)Time frame: Up to 18 weeks
Locations
18 sites in 7 countries. Site status is shown where the registry gives one.
Sichuan University-West China Second University Hospital
Chengdu, China · Recruiting
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, China · Recruiting
Guangzhou Women and Children's Medical Center
Guangzhou, China · Recruiting
The Children's Hospital Zhejiang University School of Medicine
Hangzhou, China · Recruiting
The Children's Hospital of Fudan University
Shanghai, China · Recruiting
Huazhong University of Science and Technology-Tongji Medical College-The Central Hospital of Wuhan
Wuhan, China · Recruiting
Xi'an Children's Hospital
Xi'an, China · Recruiting
Pan and Aglaia Kyriakou Children's Hospital
Athens, Greece · Recruiting
Shaare Zedek Medical Center
Jerusalem, Israel · Recruiting
Schneider Children's Medical Center of Israel
Petah Tikva, Israel · Recruiting
King Faisal Specialist Hospital and Research Center, Riyadh
Riyadh, Saudi Arabia · Recruiting
King Abdullah Specialized Children's Hospital (KASCH)
Riyadh, Saudi Arabia · Recruiting
Hospital Sant Joan de Déu
Barcelona, Spain · Recruiting
Hospital Universitario Valle de Hebron
Barcelona, Spain · Recruiting
La Paz University Hospital
Madrid, Spain · Recruiting
Jalila Children's Specialty Hospital
Dubai, United Arab Emirates · Recruiting
Royal Hospital for Children Glasgow
Glasgow, United Kingdom · Recruiting
Alder Hey Childrens NHS Foundation Trust
Liverpool, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.